2I99.A | CRYM

General Structure Information 2i99 CRYM crystal structure of human mu_crystallin at 2.6 angstrom 2.6Å AUTH Z.CHENG,L.SUN,J.HE,W.GONGTITL CRYSTAL STRUCTURE OF HUMAN {MICRO}-CRYSTALLIN COMPLEXED WITHTITL 2 NADPHREF PROTEIN SCI. V. 16 329 2007REFN ISSN 0961-8368PMID 17242435DOI 10.1110/PS.062556907 Variant Set Distributions Mapped Variants

See Details
2CT4.A | TRIP10

General Structure Information 2ct4 TRIP10 solution strutcure of the sh3 domain of the cdc42- interacting protein 4 -1.0Å AUTH K.MIYAMOTO,T.TOMIZAWA,S.KOSHIBA,M.INOUE,T.KIGAWA,AUTH 2 S.YOKOYAMATITL SOLUTION STRUTCURE OF THE SH3 DOMAIN OF THETITL 2 CDC42-INTERACTING PROTEIN 4REF TO BE PUBLISHEDREFN Variant Set Distributions Mapped Variants

See Details
2E5O.A | TRIP4

General Structure Information 2e5o TRIP4 solution structure of the trip_4c domain of target of activating signal cointegrator 1 -1.0Å AUTH W.DANG,Y.MUTO,M.INOUE,T.KIGAWA,M.SHIROUZU,T.TERADA,AUTH 2 S.YOKOYAMATITL SOLUTION STRUCTURE OF THE TRIP_4C DOMAIN OF TARGETTITL 2 OF ACTIVATING SIGNAL COINTEGRATOR 1REF TO BE PUBLISHEDREFN Variant Set Distributions Mapped Variants

See Details
2E5O.A | TRIP4

General Structure Information 2e5o TRIP4 solution structure of the trip_4c domain of target of activating signal cointegrator 1 -1.0Å AUTH W.DANG,Y.MUTO,M.INOUE,T.KIGAWA,M.SHIROUZU,T.TERADA,AUTH 2 S.YOKOYAMATITL SOLUTION STRUCTURE OF THE TRIP_4C DOMAIN OF TARGETTITL 2 OF ACTIVATING SIGNAL COINTEGRATOR 1REF TO BE PUBLISHEDREFN Variant Set Distributions Mapped Variants

See Details
2E5O.A | TRIP4

General Structure Information 2e5o TRIP4 solution structure of the trip_4c domain of target of activating signal cointegrator 1 -1.0Å AUTH W.DANG,Y.MUTO,M.INOUE,T.KIGAWA,M.SHIROUZU,T.TERADA,AUTH 2 S.YOKOYAMATITL SOLUTION STRUCTURE OF THE TRIP_4C DOMAIN OF TARGETTITL 2 OF ACTIVATING SIGNAL COINTEGRATOR 1REF TO BE PUBLISHEDREFN Variant Set Distributions Mapped Variants

See Details
2E5O.A | TRIP4

General Structure Information 2e5o TRIP4 solution structure of the trip_4c domain of target of activating signal cointegrator 1 -1.0Å AUTH W.DANG,Y.MUTO,M.INOUE,T.KIGAWA,M.SHIROUZU,T.TERADA,AUTH 2 S.YOKOYAMATITL SOLUTION STRUCTURE OF THE TRIP_4C DOMAIN OF TARGETTITL 2 OF ACTIVATING SIGNAL COINTEGRATOR 1REF TO BE PUBLISHEDREFN Variant Set Distributions Mapped Variants

See Details
2E5O.A | TRIP4

General Structure Information 2e5o TRIP4 solution structure of the trip_4c domain of target of activating signal cointegrator 1 -1.0Å AUTH W.DANG,Y.MUTO,M.INOUE,T.KIGAWA,M.SHIROUZU,T.TERADA,AUTH 2 S.YOKOYAMATITL SOLUTION STRUCTURE OF THE TRIP_4C DOMAIN OF TARGETTITL 2 OF ACTIVATING SIGNAL COINTEGRATOR 1REF TO BE PUBLISHEDREFN Variant Set Distributions Mapped Variants

See Details
1X61.A | TRIP6

General Structure Information 1×61 TRIP6 solution structure of the first lim domain of thyroid receptor interacting protein 6 (trip6) -1.0Å AUTH X.R.QIN,T.NAGASHIMA,F.HAYASHI,S.YOKOYAMATITL SOLUTION STRUCTURE OF THE FIRST LIM DOMAIN OFTITL 2 THYROID RECEPTOR INTERACTING PROTEIN 6 (TRIP6)REF TO BE PUBLISHEDREFN Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants

See Details
1X61.A | TRIP6

General Structure Information 1×61 TRIP6 solution structure of the first lim domain of thyroid receptor interacting protein 6 (trip6) -1.0Å AUTH X.R.QIN,T.NAGASHIMA,F.HAYASHI,S.YOKOYAMATITL SOLUTION STRUCTURE OF THE FIRST LIM DOMAIN OFTITL 2 THYROID RECEPTOR INTERACTING PROTEIN 6 (TRIP6)REF TO BE PUBLISHEDREFN Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants

See Details
1X61.A | TRIP6

General Structure Information 1×61 TRIP6 solution structure of the first lim domain of thyroid receptor interacting protein 6 (trip6) -1.0Å AUTH X.R.QIN,T.NAGASHIMA,F.HAYASHI,S.YOKOYAMATITL SOLUTION STRUCTURE OF THE FIRST LIM DOMAIN OFTITL 2 THYROID RECEPTOR INTERACTING PROTEIN 6 (TRIP6)REF TO BE PUBLISHEDREFN Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants

See Details